期刊文献+

S100A4在食管鳞癌上皮间质转化过程中的作用及其分子机制 被引量:3

Role of S100A4 in the epithelial-mesenchymal transition of esophageal squamous cell carcinoma and its molecular mechanism
原文传递
导出
摘要 目的探讨钙结合蛋白S100A4在食管鳞癌上皮间质转化(EMT)过程中的作用及其可能的分子机制。方法化学合成靶向S100A4的3对siRNA序列瞬时转染EC9706细胞,同时以转染阴性对照siRNA、脂质体和空白EC9706细胞作为对照,荧光定量RT—PCR和Westernblot法检测其抑制效率。将抑制效果最佳的S100A4siRNA2以相同条件转染食管癌EC9706细胞,同时以转染阴性对照siRNA、脂质体和空白EC9706细胞作为对照;然后在转染S100A4siRNA2的EC9706细胞中转染snarl真核表达载体,并以S100A4siRNA2组、snail真核表达载体组和空白组为对照,分别采用荧光定量RT—PCR和Westernblot法检测E—cadherin、vimentin和snail的表达,倒置显微镜观察各组EC9706细胞形态变化,Boydenchamber和划痕实验检测各组EC9706细胞侵袭迁移能力的变化,CCK-8法检测各组EC9706细胞增殖能力的变化。结果S100A4siRNA2组S100A4mRNA和蛋白的相对表达量分别为0.417±0.041和0.337±0.039,穿膜细胞数为(61.608±8.937)个,划痕愈合距离为(0.216±0.064)mm,A值为0.623±0.084,E—cadherinmRNA和蛋白的相对表达量分别为0.619±0.032和0.495±0.034,vimentin mRNA和蛋白的相对表达量分别为0.514±0.032和0.427±0.028,snailmRNA和蛋白的相对表达量分别为0.573±0.029和0.429±0.041,与脂质体组、阴性对照组和空白组比较,差异均有统计学意义(均P〈0.05)。S100A4siRNA2作用于EC9706细胞24h后,细胞形态向上皮细胞形态转变,呈去梭形化趋势。S100A4siRNA2+snail真核表达载体组的穿膜细胞数和划痕愈合距离分别为(69.382±9.666)个和(0.274±0.029)mm,A值为0.823±0.101,snailmRNA和蛋白的相对表达量分别为0.704±0.037和0.625±0.031,vimentinmRNA和蛋白的相对表达量分别为0.712±0.046和0.609±0.038,高于S100A4siRNA2组(均P〈0.05);S100A4siRNA2+snail真核表达载体组中E—cadhefinmRNA和蛋白的相对表达量分别为0.437±0.038和0.381±0.031,低于S100A4siRNA2组(均P〈0.05)。但snail表达增高对EC9706细胞形态无影响。结论S100A4可通过调控snail的表达参与食管癌EMT过程,进而在食管癌浸润转移中发挥作用。 Objective To explore the role of S100A4 in the epithelial-mesenchymal transition (EMT) in esophageal squamous cell carcinoma and its possible molecular mechanism. Methods Three chemically synthesized S100A4 siRNA sequences were transiently transfected into esophageal carcinoma EC9706 cells. EC9706 cells transfected with negative siRNA, lipofeetamine 2000, and vacant EC9706 cells were used as control. Fluorescence quantitative RT-PCR and Western blot were used to detect the inhibition rate of S100A4 siRNA. SIOOA4 siRNA2 with the best inhibition rate was chosen to transiently transfect into EC9706 cells under the same conditions. The EC9706 cells transfected with negative siRNA, lipofectamine 2000 and vacant EC9706 cells were also used as control. Fluorescence quantitative RT-PCR and Western blot were used to detect the mRNA and protein expressions of E-cadherin, vimentin and snail. The morphology of EC9706 cells was observed under an inverted microscope. Boyden chamber and scratch test were used to detect the invasion and migration ability of EC9706 cells, and CCK8 assay was used to detect the proliferation ability of EC9706 cells. EC9706 cells transfected with S100A4 siRNA2 were further transfected with snail eukaryotic expression vector. The EC9706 cells transfected with S100A4 siRNA, EC9706 cells transfected with snail eukaryotic expression vector and vacant EC9706 cells were used as control. The above indexes of all the groups were observed, too. Results The S100A4 mRNA and protein expression levels of the S100A4 siRNA2 group were 0.417±0.041 and 0.337±0.039, the transmembrane cell number was 61.608±8.937, the scratch healing distance was (0.216+0.064) mm, the A value was 0.623±0.084, the E-cadherin mRNA and protein levels were 0.619±0.032 and 0.495±0.034, the vimentin mRNA and protein levels were 0.514±0.032 and 0.427±0.028, the snail mRNA and protein levels were 0.573±0.029 and 0.429±0.041. These data were significantly different with the liposome group, the negative control group and the blank group (P〈0.05 for all). After the S100A4 siRNA2 treatment for 24 h, the appearance of EC9706 cells changed to epithelial cell morphology. The transmembrane cell number and the scratch healing distance of the S100A4 siRNA2+snail eukaryotic expression vector group were (69.382±9.666) cells and (0.274±0.029) mm, the A value was 0.823±0.101, the snail mRNA and protein levels were 0.704±0.037 and 0.625±0.031, the vimentin mRNA and protein levels were 0.712±0.046 and 0.609±0.038, and these data were significantly higher than those of the SIOOA4 siRNA2 group (P〈0.05 for all). The E-cadherin mRNA and protein levels of the S100A4 siRNA2 + eukaryotic expression vector group were 0.437 ±0.038 and 0.381 ±0.031, significantly lower than those of the S100A4 siRNA2 group (P〈0.05 for all). However, snail had no effect on the morphology of EC9706 ceils. Conclusions S100A4 may be involved in the EMT process of esophageal squamous-cell carcinoma by regulating the expression of snail and then plays a role in the invasion and metastasis of esophageal carcinoma.
出处 《中华肿瘤杂志》 CAS CSCD 北大核心 2015年第4期258-265,共8页 Chinese Journal of Oncology
基金 河南省科技厅科技攻关项目(072102310054)
关键词 食管肿瘤 鳞状细胞 S100A4 上皮间质转化 Esophageal neoplasms Carcinoma, squamous cell S100A4 Epithelialmesenchymal transformation
  • 相关文献

参考文献17

二级参考文献103

  • 1于观贞,王杰军,陈颖,倪灿荣,朱明华.转移相关基因nm23和P53及S100A4在晚期胃癌中的表达及与侵袭转移的相关性研究[J].中华胃肠外科杂志,2006,9(2):165-169. 被引量:23
  • 2Greenburg G, Hay ED. Epithelia suspended in collagen gels can lose polarity and express characteristics of migrating mesen- chymal cells[J].J Cell Biol, 1982,95(1 ) :333-339.
  • 3Nakajima S, Doi R, Toyoda E, et al. N-cadherin expression and epithelial-mesenchymal transiuon in pancreauc carcinoma[J]. Clin Cancer Res,2004,10(12ptl):4125-4133.
  • 4Lascombe I, Clairotte A, Fauconnet S, et al. N-cadherin as a novel prognostic marker of progression in superficial urothelial tumors[J]. Clin Cancer Res, 2006,12 (9) : 2780-2787.
  • 5Pyo SW, Hashimoto M, Kim YS, et al. Expression of E-cad- herin, P-cadherin and N-cadherin in oral squamous cell carci-noma: correlation with the clinicopathologic features and pa tient outcome[J]. J Craniomaxillofac Surg, 2007,35(1) : 1- 9.
  • 6Cavallaro U, Schaffhauser B, Christofori C-. Cadherins and tile tumor progression: is it all in a switch ? [J]. Cancer I.ett, 2002, 176 (2) :123 - 128.
  • 7Wheelock MJ, Shintani Y, Maeda M, et al. Cadherin swilc hing [J]. J Cell Sci,2008,121 (pt6) :727 -735.
  • 8Hulit J, Suyama K, Chung S, et al. N cadherin signaling po- tentiates mammary tumor metastasis via enhanced extracellular signal regulated kinase activation[J]. Cancer Res, 2007 , 67 (7) :3106-3116.
  • 9Onder TT, Gupta PB, Mani SA, et al. Loss of E cadherin promotes metastasis via multiple downstream transcriplional pathways[J]. Cancer Res, 2008,68 (10) :3645-3654.
  • 10Devemy E,Blaschuk OW. Identification of a novel dual E and N-cadherin antagonist [J].Peptides, 2009,30 (8) : 1539-1547.

共引文献60

同被引文献9

引证文献3

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部